A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis

Clinical trial NCT01949051 · COMPLETED

Trial details

NCT number: NCT01949051
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial and Seasonal

Start date: 2013-10-01
Primary completion: 2014-02-04
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.